The Effect of Dexmedetomidine on Inflammatory Response of Septic Rats

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2015 May 2

PMID 25929655

Citations 34

Authors

Jianxing Zhang

Zhipeng Wang

Yan Wang

Guobin Zhou

Hongying Li

Affiliations

Soon will be listed here.

Abstract

Background: Some studies have demonstrated dexmedetomidine has anti-inflammatory effect on septic rats. However, the mechanism of how dexmedetomidine exerts these effects is still remained unknown. This study was designed to investigate the mechanism of how dexmedetomidine inhibits the production of inflammatory mediators in cecal ligation and puncturinduced septic rats.

Methods: 48 Sprague-Dawley rats were randomly divided into six groups: sham-operated (sham) group, cecal ligation and puncture (CLP) group, dexmedetomidine 5 μg/kg (DEX5) group, dexmedetomidine 10 μg/kg (DEX10) group,dexmedetomidine + yohimbine (DEX10 + Yoh) group and yohimibine group (Yoh). Blood, bronchoalveolarlavage fluid (BALF) and lung tissues in each group were collected at six hours after dexmedetomidine or yohimbine treatment,. Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in BALF and plasma were measured by enzyme-linked immunosorbent assay (ELISA). Toll-like receptor-4(TLR4) and myeloid differerntiation factor(MyD88) expression were measuredby quantitative PCR, and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation were determined by western blott.

Results: Compared with CLP group, dexmedetomidine significantly decreased not only the production of TNF-α and IL-6 both in plasma and BALF, but also inhibited the expression of TLR4 and MyD88 in mRNA level and the activation of ERK1/2 and NF-κB in the lung tissues of CLP-induced septic rats. All these effects could not be reversed by yohimibine.

Conclusions: Dexmedetomidine treatment can effectively reduce the generation of inflammatory mediators in the plasma and BALF of CLP-induced septic rats. These effects of dexmedetomidine rely on TLR4/MyD88/MAPK/ NF-κB signaling pathway and are independent of α2-adrenoceptor.

Citing Articles

The significant mechanism and treatments of cell death in heatstroke.

Wang Z, Zhu J, Zhang D, Lv J, Wu L, Liu Z Apoptosis. 2024; 29(7-8):967-980.

PMID: 38886312 DOI: 10.1007/s10495-024-01979-w.

Impact of a Dexmedetomidine Intravenous Infusion in Septic Dogs: Preliminary Study.

Di Franco C, Boysen S, Vannozzi I, Briganti A Animals (Basel). 2024; 14(6).

PMID: 38539990 PMC: 10967601. DOI: 10.3390/ani14060892.

Synergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models.

Fang Y, Xiao C, Wang L, Wang Y, Zeng J, Liang Y J Inflamm Res. 2023; 16:5989-6001.

PMID: 38088941 PMC: 10712681. DOI: 10.2147/JIR.S421232.

Role of dexmedetomidine in modifying immune paralysis in patients with septic shock: randomized controlled trial.

Elayashy M, Elsayed E, Mukhtar A, Kasem S, Elmetwally S, Habib S Intensive Care Med Exp. 2023; 11(1):59.

PMID: 37665397 PMC: 10477149. DOI: 10.1186/s40635-023-00542-2.

The Effects of Dexmedetomidine on Perioperative Neurocognitive Outcomes After Noncardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Singh A, Broad J, Brenna C, Kaustov L, Choi S Ann Surg Open. 2023; 3(1):e130.

PMID: 37600088 PMC: 10431438. DOI: 10.1097/AS9.0000000000000130.

References

Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S . Toll-like receptor signal transduction. Exp Mol Med. 2007; 39(4):421-38. DOI: 10.1038/emm.2007.47. View

Koay M, Gao X, Washington M, Parman K, Sadikot R, Blackwell T . Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am J Respir Cell Mol Biol. 2002; 26(5):572-8. DOI: 10.1165/ajrcmb.26.5.4748. View

Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F . Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia. 2008; 56(12):1312-9. DOI: 10.1002/glia.20699. View

Rittirsch D, Huber-Lang M, Flierl M, Ward P . Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009; 4(1):31-6. PMC: 2754226. DOI: 10.1038/nprot.2008.214. View

Arumugam T, Okun E, Tang S, Thundyil J, Taylor S, Woodruff T . Toll-like receptors in ischemia-reperfusion injury. Shock. 2008; 32(1):4-16. DOI: 10.1097/SHK.0b013e318193e333. View

Qiao H, Sanders R, Ma D, Wu X, Maze M . Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care. 2009; 13(4):R136. PMC: 2750194. DOI: 10.1186/cc8012. View

Tasdogan M, Memis D, Sut N, Yuksel M . Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth. 2009; 21(6):394-400. DOI: 10.1016/j.jclinane.2008.10.010. View

Schottelius A, Zugel U, Docke W, Zollner T, Rose L, Mengel A . The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation. J Invest Dermatol. 2009; 130(2):481-91. DOI: 10.1038/jid.2009.218. View

Sezer A, Memis D, Usta U, Sut N . The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study. Ulus Travma Acil Cerrahi Derg. 2010; 16(2):108-12. View

10.

Saito O, Svensson C, Buczynski M, Wegner K, Hua X, Codeluppi S . Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol. 2010; 160(7):1754-64. PMC: 2936846. DOI: 10.1111/j.1476-5381.2010.00811.x. View

11.

Aktunc E, Kayhan B, Arasli M, Dogan Gun B, Barut F . The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol. 2011; 33(4):667-75. DOI: 10.3109/08923973.2011.559475. View

12.

ONeill L, Bowie A . The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007; 7(5):353-64. DOI: 10.1038/nri2079. View

13.

Memis D, Hekimoglu S, Vatan I, Yandim T, Yuksel M, Sut N . Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth. 2007; 98(4):550-2. DOI: 10.1093/bja/aem017. View

14.

DeLong P, Murray J, Cook C . Mechanical ventilation in the management of acute respiratory distress syndrome. Semin Dial. 2006; 19(6):517-24. DOI: 10.1111/j.1525-139X.2006.00215.x. View

15.

Shimamoto A, Pohlman T, Shomura S, Tarukawa T, Takao M, Shimpo H . Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg. 2006; 82(6):2017-23. DOI: 10.1016/j.athoracsur.2006.06.079. View

16.

Mollen K, Anand R, Tsung A, Prince J, Levy R, Billiar T . Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock. 2006; 26(5):430-7. DOI: 10.1097/01.shk.0000228797.41044.08. View

17.

Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R . Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J Pharmacol Exp Ther. 2006; 318(1):68-78. DOI: 10.1124/jpet.106.103192. View

18.

Aharoni R, Kayhan B, Arnon R . Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis. Inflamm Bowel Dis. 2005; 11(2):106-15. DOI: 10.1097/00054725-200502000-00003. View

19.

Chow J, Young D, Golenbock D, Christ W, Gusovsky F . Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999; 274(16):10689-92. DOI: 10.1074/jbc.274.16.10689. View

20.

Baeuerle P, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994; 12:141-79. DOI: 10.1146/annurev.iy.12.040194.001041. View